Review





Similar Products

94
Shanghai Korain Biotech Co Ltd sema3a
Sema3a, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sema3a/product/Shanghai Korain Biotech Co Ltd
Average 94 stars, based on 1 article reviews
sema3a - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
MedChemExpress sema3a antagonist sm345431
Sema3a Antagonist Sm345431, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sema3a antagonist sm345431/product/MedChemExpress
Average 93 stars, based on 1 article reviews
sema3a antagonist sm345431 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Proteintech sema3a
(A) RUNX2 immunofluorescence staining. (B) Western blotting of RUNX2. (C) Quantitative results of RUNX2 western blotting. (D) The transcriptional expression level of <t>Sema3A.</t> (E) Western blotting of <t>Sema3A.</t> (F) Quantitative results of Sema3A western blotting. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.
Sema3a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sema3a/product/Proteintech
Average 93 stars, based on 1 article reviews
sema3a - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Proteintech antisema3a
(A) RUNX2 immunofluorescence staining. (B) Western blotting of RUNX2. (C) Quantitative results of RUNX2 western blotting. (D) The transcriptional expression level of <t>Sema3A.</t> (E) Western blotting of <t>Sema3A.</t> (F) Quantitative results of Sema3A western blotting. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.
Antisema3a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antisema3a/product/Proteintech
Average 93 stars, based on 1 article reviews
antisema3a - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Thermo Fisher gene exp sema3a hs00173810 m1
(A) RUNX2 immunofluorescence staining. (B) Western blotting of RUNX2. (C) Quantitative results of RUNX2 western blotting. (D) The transcriptional expression level of <t>Sema3A.</t> (E) Western blotting of <t>Sema3A.</t> (F) Quantitative results of Sema3A western blotting. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.
Gene Exp Sema3a Hs00173810 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp sema3a hs00173810 m1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
gene exp sema3a hs00173810 m1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Advanced Cell Diagnostics Inc c2 probe labeled hs-sema3a
(A) RUNX2 immunofluorescence staining. (B) Western blotting of RUNX2. (C) Quantitative results of RUNX2 western blotting. (D) The transcriptional expression level of <t>Sema3A.</t> (E) Western blotting of <t>Sema3A.</t> (F) Quantitative results of Sema3A western blotting. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.
C2 Probe Labeled Hs Sema3a, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c2 probe labeled hs-sema3a/product/Advanced Cell Diagnostics Inc
Average 90 stars, based on 1 article reviews
c2 probe labeled hs-sema3a - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Cusabio mouse semaphorin 3a elisa kit
(A) Representative flow cytometry gating of WT/ Mrgprb2 −/− brains 48h post-tMCAO. left , Live cells are gated using an immune marker (CD45) and myeloid marker (CD11b). right , Myeloid cells are gated using Ly6G and Ly6C to delineate CD45-high neutrophils and monocytes/macrophages, and CD45-low microglia. (B-D) (B) Absolute count of neutrophils, (C) monocytes/macrophages, and (D) CD11b-positive microglia in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice 48h post-tMCAO (WT n =18, Mrgprb2 −/− n =16). (E) Representative immunofluorescence images of WT (left)/ Mrgprb2 −/− (right) right brain hemispheres 48h post-tMCAO. top row, CD45-positive immune cells. middle row, GFAP-positive activated astrocytes. Dotted white line separates infarcted tissue without GFAP and live, injured brain tissue with GFAP. bottom row, Merged channels with DAPI. Scale bar=50 μm. (F), left, CCL2 and right, CCL3 protein expression measured by <t>ELISA</t> in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (CCL2: WT n =6, Mrgprb2 −/− n =6, CCL3: WT n =5, Mrgprb2 −/− n =5). (G-H) (G) IL-6 and (H) neutrophil elastase protein expression measured by ELISA in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (G, WT n =5, Mrgprb2 −/− n =5, H, WT n =7, Mrgprb2 −/− n =7). (I) Representative immunofluorescence image of Mrgprb2 −/− mouse meninges 8 weeks after engraftment with Mrgprb2-tdT mast cells. left column, tdT denotes engrafted cells. middle column, Avidin denotes all mast cells. right column, Merged channels with DAPI. Scale bar=50 μm. (J) Mast cell count in meninges of Mrgprb2 −/− mice engrafted with saline, WT, or Mrgprb2 −/− mast cells, determined by Avidin-positive cells in the dura, using a 0.408mm 2 viewing frame (WT saline n =4, WT engraftment n =5, Mrgprb2 −/− saline n =4, Mrgprb2 −/− engraftment n =4). (K) Absolute count of neutrophils and monocytes/macrophages in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mast cell engrafted mice (WT n =16, Mrgprb2 −/− n =18). (L). left, Representative T2-weighted MRIs, and right , stroke volume of WT/ Mrgprb2 −/− MC-engrafted Mrgprb2 −/− mice 48h post-tMCAO (WT n =9, Mrgprb2 −/− n =8). Statistical analyses: Kruskal-Wallis test (B and G), two-way ANOVA with Sidak’s multiple comparisons test (C-D, F, H, and J-K), and two-sided Student’s t-test (L). Statistical test for C, D, and K was performed on log-transformed data to adjust for non-normality. Bar graphs indicate mean ± SEM. * P < 0.05, ** P < 0.01, **** P < 0.0001.
Mouse Semaphorin 3a Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse semaphorin 3a elisa kit/product/Cusabio
Average 93 stars, based on 1 article reviews
mouse semaphorin 3a elisa kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
MedChemExpress mouse
(A) Representative flow cytometry gating of WT/ Mrgprb2 −/− brains 48h post-tMCAO. left , Live cells are gated using an immune marker (CD45) and myeloid marker (CD11b). right , Myeloid cells are gated using Ly6G and Ly6C to delineate CD45-high neutrophils and monocytes/macrophages, and CD45-low microglia. (B-D) (B) Absolute count of neutrophils, (C) monocytes/macrophages, and (D) CD11b-positive microglia in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice 48h post-tMCAO (WT n =18, Mrgprb2 −/− n =16). (E) Representative immunofluorescence images of WT (left)/ Mrgprb2 −/− (right) right brain hemispheres 48h post-tMCAO. top row, CD45-positive immune cells. middle row, GFAP-positive activated astrocytes. Dotted white line separates infarcted tissue without GFAP and live, injured brain tissue with GFAP. bottom row, Merged channels with DAPI. Scale bar=50 μm. (F), left, CCL2 and right, CCL3 protein expression measured by <t>ELISA</t> in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (CCL2: WT n =6, Mrgprb2 −/− n =6, CCL3: WT n =5, Mrgprb2 −/− n =5). (G-H) (G) IL-6 and (H) neutrophil elastase protein expression measured by ELISA in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (G, WT n =5, Mrgprb2 −/− n =5, H, WT n =7, Mrgprb2 −/− n =7). (I) Representative immunofluorescence image of Mrgprb2 −/− mouse meninges 8 weeks after engraftment with Mrgprb2-tdT mast cells. left column, tdT denotes engrafted cells. middle column, Avidin denotes all mast cells. right column, Merged channels with DAPI. Scale bar=50 μm. (J) Mast cell count in meninges of Mrgprb2 −/− mice engrafted with saline, WT, or Mrgprb2 −/− mast cells, determined by Avidin-positive cells in the dura, using a 0.408mm 2 viewing frame (WT saline n =4, WT engraftment n =5, Mrgprb2 −/− saline n =4, Mrgprb2 −/− engraftment n =4). (K) Absolute count of neutrophils and monocytes/macrophages in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mast cell engrafted mice (WT n =16, Mrgprb2 −/− n =18). (L). left, Representative T2-weighted MRIs, and right , stroke volume of WT/ Mrgprb2 −/− MC-engrafted Mrgprb2 −/− mice 48h post-tMCAO (WT n =9, Mrgprb2 −/− n =8). Statistical analyses: Kruskal-Wallis test (B and G), two-way ANOVA with Sidak’s multiple comparisons test (C-D, F, H, and J-K), and two-sided Student’s t-test (L). Statistical test for C, D, and K was performed on log-transformed data to adjust for non-normality. Bar graphs indicate mean ± SEM. * P < 0.05, ** P < 0.01, **** P < 0.0001.
Mouse, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse/product/MedChemExpress
Average 93 stars, based on 1 article reviews
mouse - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


(A) RUNX2 immunofluorescence staining. (B) Western blotting of RUNX2. (C) Quantitative results of RUNX2 western blotting. (D) The transcriptional expression level of Sema3A. (E) Western blotting of Sema3A. (F) Quantitative results of Sema3A western blotting. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.

Journal: PLOS One

Article Title: Effects and mechanisms of engineered exosomes pretreated with Scutellaria baicalensis Georgi on osteoporosis

doi: 10.1371/journal.pone.0333897

Figure Lengend Snippet: (A) RUNX2 immunofluorescence staining. (B) Western blotting of RUNX2. (C) Quantitative results of RUNX2 western blotting. (D) The transcriptional expression level of Sema3A. (E) Western blotting of Sema3A. (F) Quantitative results of Sema3A western blotting. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.

Article Snippet: Antibodies targeting RUNX2 and Sema3A were obtained by Proteintech (Wuhan, China).

Techniques: Immunofluorescence, Staining, Western Blot, Expressing

(A) Volcano plot showing differentially expressed genes. (B) Heatmap illustrating expression patterns of Sema3A-related genes. (C) WB analysis confirming the elevated Sema3A levels in S-EXOs@BMSCs compared with EXOs@BMSCs. (D) Representative images and quantitative analysis demonstrating that inhibition of Sema3A attenuates the osteogenic effects of S-EXOs@BMSCs. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.

Journal: PLOS One

Article Title: Effects and mechanisms of engineered exosomes pretreated with Scutellaria baicalensis Georgi on osteoporosis

doi: 10.1371/journal.pone.0333897

Figure Lengend Snippet: (A) Volcano plot showing differentially expressed genes. (B) Heatmap illustrating expression patterns of Sema3A-related genes. (C) WB analysis confirming the elevated Sema3A levels in S-EXOs@BMSCs compared with EXOs@BMSCs. (D) Representative images and quantitative analysis demonstrating that inhibition of Sema3A attenuates the osteogenic effects of S-EXOs@BMSCs. Significance levels are indicated as follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.

Article Snippet: Antibodies targeting RUNX2 and Sema3A were obtained by Proteintech (Wuhan, China).

Techniques: Expressing, Inhibition

(A) Mouse femurs were analyzed using H&E and Masson’s trichrome staining techniques. (B) The fluorescence staining results of OCN, TRAP, and Sema3A triple co-staining in mouse femurs.

Journal: PLOS One

Article Title: Effects and mechanisms of engineered exosomes pretreated with Scutellaria baicalensis Georgi on osteoporosis

doi: 10.1371/journal.pone.0333897

Figure Lengend Snippet: (A) Mouse femurs were analyzed using H&E and Masson’s trichrome staining techniques. (B) The fluorescence staining results of OCN, TRAP, and Sema3A triple co-staining in mouse femurs.

Article Snippet: Antibodies targeting RUNX2 and Sema3A were obtained by Proteintech (Wuhan, China).

Techniques: Staining, Fluorescence

(A) Representative flow cytometry gating of WT/ Mrgprb2 −/− brains 48h post-tMCAO. left , Live cells are gated using an immune marker (CD45) and myeloid marker (CD11b). right , Myeloid cells are gated using Ly6G and Ly6C to delineate CD45-high neutrophils and monocytes/macrophages, and CD45-low microglia. (B-D) (B) Absolute count of neutrophils, (C) monocytes/macrophages, and (D) CD11b-positive microglia in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice 48h post-tMCAO (WT n =18, Mrgprb2 −/− n =16). (E) Representative immunofluorescence images of WT (left)/ Mrgprb2 −/− (right) right brain hemispheres 48h post-tMCAO. top row, CD45-positive immune cells. middle row, GFAP-positive activated astrocytes. Dotted white line separates infarcted tissue without GFAP and live, injured brain tissue with GFAP. bottom row, Merged channels with DAPI. Scale bar=50 μm. (F), left, CCL2 and right, CCL3 protein expression measured by ELISA in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (CCL2: WT n =6, Mrgprb2 −/− n =6, CCL3: WT n =5, Mrgprb2 −/− n =5). (G-H) (G) IL-6 and (H) neutrophil elastase protein expression measured by ELISA in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (G, WT n =5, Mrgprb2 −/− n =5, H, WT n =7, Mrgprb2 −/− n =7). (I) Representative immunofluorescence image of Mrgprb2 −/− mouse meninges 8 weeks after engraftment with Mrgprb2-tdT mast cells. left column, tdT denotes engrafted cells. middle column, Avidin denotes all mast cells. right column, Merged channels with DAPI. Scale bar=50 μm. (J) Mast cell count in meninges of Mrgprb2 −/− mice engrafted with saline, WT, or Mrgprb2 −/− mast cells, determined by Avidin-positive cells in the dura, using a 0.408mm 2 viewing frame (WT saline n =4, WT engraftment n =5, Mrgprb2 −/− saline n =4, Mrgprb2 −/− engraftment n =4). (K) Absolute count of neutrophils and monocytes/macrophages in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mast cell engrafted mice (WT n =16, Mrgprb2 −/− n =18). (L). left, Representative T2-weighted MRIs, and right , stroke volume of WT/ Mrgprb2 −/− MC-engrafted Mrgprb2 −/− mice 48h post-tMCAO (WT n =9, Mrgprb2 −/− n =8). Statistical analyses: Kruskal-Wallis test (B and G), two-way ANOVA with Sidak’s multiple comparisons test (C-D, F, H, and J-K), and two-sided Student’s t-test (L). Statistical test for C, D, and K was performed on log-transformed data to adjust for non-normality. Bar graphs indicate mean ± SEM. * P < 0.05, ** P < 0.01, **** P < 0.0001.

Journal: Cell

Article Title: A mast cell receptor mediates post-stroke brain inflammation via a dural-brain axis

doi: 10.1016/j.cell.2025.06.045

Figure Lengend Snippet: (A) Representative flow cytometry gating of WT/ Mrgprb2 −/− brains 48h post-tMCAO. left , Live cells are gated using an immune marker (CD45) and myeloid marker (CD11b). right , Myeloid cells are gated using Ly6G and Ly6C to delineate CD45-high neutrophils and monocytes/macrophages, and CD45-low microglia. (B-D) (B) Absolute count of neutrophils, (C) monocytes/macrophages, and (D) CD11b-positive microglia in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice 48h post-tMCAO (WT n =18, Mrgprb2 −/− n =16). (E) Representative immunofluorescence images of WT (left)/ Mrgprb2 −/− (right) right brain hemispheres 48h post-tMCAO. top row, CD45-positive immune cells. middle row, GFAP-positive activated astrocytes. Dotted white line separates infarcted tissue without GFAP and live, injured brain tissue with GFAP. bottom row, Merged channels with DAPI. Scale bar=50 μm. (F), left, CCL2 and right, CCL3 protein expression measured by ELISA in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (CCL2: WT n =6, Mrgprb2 −/− n =6, CCL3: WT n =5, Mrgprb2 −/− n =5). (G-H) (G) IL-6 and (H) neutrophil elastase protein expression measured by ELISA in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mice (G, WT n =5, Mrgprb2 −/− n =5, H, WT n =7, Mrgprb2 −/− n =7). (I) Representative immunofluorescence image of Mrgprb2 −/− mouse meninges 8 weeks after engraftment with Mrgprb2-tdT mast cells. left column, tdT denotes engrafted cells. middle column, Avidin denotes all mast cells. right column, Merged channels with DAPI. Scale bar=50 μm. (J) Mast cell count in meninges of Mrgprb2 −/− mice engrafted with saline, WT, or Mrgprb2 −/− mast cells, determined by Avidin-positive cells in the dura, using a 0.408mm 2 viewing frame (WT saline n =4, WT engraftment n =5, Mrgprb2 −/− saline n =4, Mrgprb2 −/− engraftment n =4). (K) Absolute count of neutrophils and monocytes/macrophages in contralateral/stroke brain hemispheres of WT/ Mrgprb2 −/− mast cell engrafted mice (WT n =16, Mrgprb2 −/− n =18). (L). left, Representative T2-weighted MRIs, and right , stroke volume of WT/ Mrgprb2 −/− MC-engrafted Mrgprb2 −/− mice 48h post-tMCAO (WT n =9, Mrgprb2 −/− n =8). Statistical analyses: Kruskal-Wallis test (B and G), two-way ANOVA with Sidak’s multiple comparisons test (C-D, F, H, and J-K), and two-sided Student’s t-test (L). Statistical test for C, D, and K was performed on log-transformed data to adjust for non-normality. Bar graphs indicate mean ± SEM. * P < 0.05, ** P < 0.01, **** P < 0.0001.

Article Snippet: Mouse Semaphorin 3A ELISA Kit , Cusabio , Cat#: CSB-EL020980MO.

Techniques: Flow Cytometry, Marker, Immunofluorescence, Expressing, Enzyme-linked Immunosorbent Assay, Avidin-Biotin Assay, Cell Counting, Saline, Transformation Assay